New Key Statistics Module, Z-Score and F-Score
OTCPK:SMPQY Key Ratios
Market Cap $ M | -- |
Enterprise Value $ M | 16,422.49 |
P/E(ttm) | 43.81 |
PE Ratio without NRI | 43.49 |
Forward PE Ratio | 37.31 |
Price/Book | 7.15 |
Price/Sales | 9.38 |
Price/Free Cash Flow | 45.82 |
Price/Owner Earnings | 37.07 |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -- |
Beneish M-Score | -2.59 |
10-y EBITDA Growth Rate % | 4.10 |
5-y EBITDA Growth Rate % | 18.40 |
y-y EBITDA Growth Rate % | 19.30 |
EV-to-EBIT | 35.85 |
EV-to-EBITDA | 29.65 |
PEG | 2.36 |
Shares Outstanding M | 2,399.33 |
Net Margin (%) | 21.42 |
Operating Margin % | 22.25 |
Pre-tax Margin (%) | 24.81 |
Quick Ratio | 1.98 |
Current Ratio | 2.56 |
ROA % (ttm) | 12.69 |
ROE % (ttm) | 17.37 |
ROIC % (ttm) | 16.17 |
Dividend Yield % | -- |
Altman Z-Score | 17.11 |
SMPQY Number of Guru Trades
SMPQY Volume of Guru Trades
Gurus Latest Trades with OTCPK:SMPQY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SMPQY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sun Pharmaceuticals Industries Ltd Insider Transactions
No Available Data
News about OTCPK:SMPQY
Total 0- 1